What is Intellia Therapeutics's short- term investments?

Intellia Therapeutics (NTLA) reported short- term investments of $241.29M in Q1 2026.

How has Intellia Therapeutics's short- term investments changed year-over-year?

Intellia Therapeutics's short- term investments decreased by 36.0% year-over-year, from $376.87M to $241.29M.

What is the long-term trend for Intellia Therapeutics's short- term investments?

Over 5 years (2020 to 2025), Intellia Therapeutics's short- term investments has grown at a -7.6% compound annual growth rate (CAGR), from $437.35M to $294.42M.

Intellia Therapeutics NTLA Short- term Investments

Short- term Investments at other companies

CRISPR TherapeuticsCRSP

——

Beam TherapeuticsBEAM

——

Vera TherapeuticsVERA

——

Regeneron PharmaceuticalsREGN

——

Denali Therapeutics Inc.DNLI

——

ImmunityBio, Inc.IBRX

——

Other financials

Income statement

See full

Revenue$15.0M-9.5%

Operating income-$100.5M+16.8%

Net income-$96.2M+15.8%

EPS (diluted)-$0.81+26.4%

Balance sheet

See full

Cash & equivalents$134.7M+6.2%

Total debt$80.5M-32.5%

Total equity$620.9M-20.4%

Total assets$758.8M-23.1%

Cash flow

See full

Operating cash flow-$117.3M+21.2%

CapEx$79.0K-89.3%

Free cash flow-$117.4M+21.5%

Valuation

See full

Market cap$2.13B+106%

Enterprise value$2.08B+100%

P/S32.2×+9.5×

Profitability

See full

Operating margin-636.6%-202pp

Net margin-597%-194pp

FCF margin-550.2%-140pp

Returns & leverage

See full

Return on equity-56.3%-1.5pp

Debt / equity0.1×0.0×

Current ratio6.1×+1.2×

Where this comes from

Reported directly by Intellia Therapeutics in its filing.

Tagged under the XBRL concept us-gaap:MarketableSecuritiesCurrent.

The official record: Intellia Therapeutics’s 10-Q, filed May 11, 2026, on SEC EDGAR. View the filing →

Ask your AI about Intellia Therapeutics's short- term investments.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Intellia Therapeutics's short- term investments?: Intellia Therapeutics (NTLA) reported short- term investments of $241.29M in Q1 2026.
How has Intellia Therapeutics's short- term investments changed year-over-year?: Intellia Therapeutics's short- term investments decreased by 36.0% year-over-year, from $376.87M to $241.29M.
What is the long-term trend for Intellia Therapeutics's short- term investments?: Over 5 years (2020 to 2025), Intellia Therapeutics's short- term investments has grown at a -7.6% compound annual growth rate (CAGR), from $437.35M to $294.42M.